79 related articles for article (PubMed ID: 9436474)
1. [Familial combined hyperlipidemia].
Martin G; Shviro I; Staels B; Auwerx J
Ann Endocrinol (Paris); 1997; 58(4):283-6. PubMed ID: 9436474
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.
de Graaf J; van der Vleuten G; Stalenhoef AF
Semin Vasc Med; 2004 Aug; 4(3):229-40. PubMed ID: 15630632
[TBL] [Abstract][Full Text] [Related]
3. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
[TBL] [Abstract][Full Text] [Related]
4. [Familial combined hyperlipidemia; solution on the horizon?].
Porkka K; Taskinen MR
Duodecim; 1995; 111(18):1755-62. PubMed ID: 9340268
[No Abstract] [Full Text] [Related]
5. [Familial combined hyperlipidemia].
Takagi A; Ikeda Y
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):76-9. PubMed ID: 9645012
[No Abstract] [Full Text] [Related]
6. Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
Williams KJ; Petrie KA; Brocia RW; Swenson TL
J Clin Invest; 1991 Oct; 88(4):1300-6. PubMed ID: 1918380
[TBL] [Abstract][Full Text] [Related]
7. Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism.
Ellis KL; Hooper AJ; Burnett JR; Watts GF
Nat Rev Endocrinol; 2016 Aug; 12(8):467-84. PubMed ID: 27199287
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia.
Austin MA; Wijsman E; Guo SW; Krauss RM; Brunzell JD; Deeb S
Genet Epidemiol; 1991; 8(5):287-97. PubMed ID: 1761202
[TBL] [Abstract][Full Text] [Related]
9. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives.
Bredie SJ; Tack CJ; Smits P; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1465-71. PubMed ID: 9261281
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity.
Bredie SJ; Demacker PN; Stalenhoef AF
Eur J Clin Invest; 1997 Oct; 27(10):802-11. PubMed ID: 9373757
[No Abstract] [Full Text] [Related]
11. Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
de Graaf J; Stalenhoef AF
Curr Opin Lipidol; 1998 Jun; 9(3):189-96. PubMed ID: 9645500
[TBL] [Abstract][Full Text] [Related]
12. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
[TBL] [Abstract][Full Text] [Related]
13. MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin.
Klop B; Verseyden C; Ribalta J; Salazar J; Masana L; Cabezas MC
Clin Investig Arterioscler; 2014; 26(2):49-57. PubMed ID: 24378322
[TBL] [Abstract][Full Text] [Related]
14. Status of "familial combined hyperlipidemia".
Brunzell JD; Motulsky AG
Prog Clin Biol Res; 1984; 147():403-5. PubMed ID: 6739492
[No Abstract] [Full Text] [Related]
15. [Genetic factors in familial combined hyperlipidemia and insulin resistance syndrome associated with dyslipidemia].
Moulin P
Ann Endocrinol (Paris); 1997; 58(4):287-91. PubMed ID: 9436476
[TBL] [Abstract][Full Text] [Related]
16. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
17. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
18. [Familial combined hyperlipidemia].
Bredie SJ; Stalenhoef AF
Ned Tijdschr Geneeskd; 1996 Dec; 140(50):2528. PubMed ID: 9005339
[No Abstract] [Full Text] [Related]
19. [The detection of apolipoproteins AI and B in the liver of patients with and without hyperlipoproteinemia (author's transl)].
Hopf U; Schwartzkopff W; Assmann G; Beger HG; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1981 Jun; 19(6):284-92. PubMed ID: 6789566
[TBL] [Abstract][Full Text] [Related]
20. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
Castro Cabezas M; de Bruin TW; de Valk HW; Shoulders CC; Jansen H; Willem Erkelens D
J Clin Invest; 1993 Jul; 92(1):160-8. PubMed ID: 8100834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
